Definitive Contract 75D30123C17664
Award Date
9/29/23
Potential Completion Date
9/28/25
Potential Value
$748K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Decatur, GA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the...
The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
This is a $1,068,632.42 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pro-Change Behavior Systems, Inc., a woman-owned small business, to implement a demonstration project titled "Combining Trust, Technology & Theory in the Community to Prevent Diabetes." The project aims to leverage Black barbers and stylists to deliver a community-based diabetes prevention intervention. The contract does not have a set-aside designation....
The Centers for Disease Control and Prevention (CDC) awarded a $78,743 firm fixed price purchase order to Biocentric, Inc. to deliver a serious health game supporting a lifestyle change program for diabetes prevention. As the final report under the contract, Biocentric will report on outcomes of developing and deploying a digital game to educate at-risk individuals on diabetes prevention best practices. No subcontractors or set aside designations were specified. The CDC works extensively with...
This federal contract award, valued at $85,272.00, was issued by the Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract is for research services related to "TRUE DIABETES INCIDENCE AND DETECTION IN THE U.S. ADULT PUPLATION." This appears to be a prime contract with no set-aside designation. The services provided include compartment modeling, risk score analysis, and projections on the...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price contract to Family Health International (FHI 360), a nonprofit organization, to conduct a study titled "A New Look at Increasing Health Care Provider Referrals to National DPP Lifestyle Change Programs." The $411,890.00 contract, which does not have a set-aside designation, began on August 1, 2021 and is scheduled for completion by July 31, 2023. FHI 360 has a General...
This federal contract award, with an ID of HHSD200201587699C, was issued by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, valued at $4,986,472.00, is for DIABETES PREVENTION-DM REGISTREIS services. This is a Cost Plus Fixed Fee type contract with a definitive completion date of March 31, 2021. The contract does not have a set-aside designation. Westat, Inc. is an experienced government...
This is a $147,470.09 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Baker Heart and Diabetes Institute, a non-profit medical research facility based in Australia. The contract was for research on global and country-specific trends in the incidence of Type 2 diabetes. The contract did not have a set-aside designation. The Baker Heart and Diabetes Institute has previously performed research services as a subcontractor on federal...
This is a $2,495,629.45 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Deloitte Consulting LLP, a leading management and technology consulting firm, to identify and evaluate innovative strategies for retaining participants in the National Diabetes Prevention Program. The contract has an ultimate completion date of August 21, 2025. Deloitte has extensive experience supporting federal civilian agencies, including the CDC, through prime...